Hsa_circ_0004662 Accelerates the Progression of Ulcerative Colitis via the microRNA‐532/HMGB3 Signalling Axis
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Chunhua Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, C…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, MicroRNAs, RNA, Circular, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Administration of Traditional Chinese Medicine, Sichuan Science and Technology Department.
Abstract (Originalsprache)
Increasing research has indicated that circular RNAs (circRNAs) are crucial for the development of ulcerative colitis (UC). Thus, we attempted to identify the role of hsa_circ_0004662 in UC progression. Hsa_circ_0004662 expression was determined via qRT‐PCR. Lipopolysaccharide (LPS)‐induced inflammation in normal colonic epithelial cells (ECs). The hsa_circ_0004662 content was then assessed in a mucosal inflammatory bowel disease (IBD) model. Cell proliferation was examined via CCK‐8 and EdU uptake assays. Apoptotic rates were analysed via flow cytometry. The protein content was quantified via Western blotting. Enzyme‐linked immunosorbent assay kits were used to detect IL‐1β, TNF‐α and IL‐6, and dual‐luciferase reporter (DLR) assays were used to identify interactions between miR‐532 and circ_0004662 or HMGB3. An animal model of UC was also developed for confirmation. In this study, we identified the function of hsa_circ_0004662 in promoting UC progression. Hsa_circ_0004662 was upregulated in clinical UC tissues and LPS‐induced colonic ECs, and its knockdown inhibited apoptosis, reduced inflammatory cytokine release and promoted cell proliferation in vitro. Mechanistically, hsa_circ_0004662 acted as a molecular sponge for miR‐532, which targets HMGB3. The hsa_circ_0004662/miR‐532/HMGB3 axis was further validated in a DSS‐induced colitis mouse model, where hsa_circ_0004662 knockdown attenuated inflammation and tissue damage. These findings suggested that hsa_circ_0004662 contributes to UC progression through the miR‐532/HMGB3 signalling pathway, offering potential targets for UC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Geriatric Gastroenterology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Geriatrics Research Institute, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
ORCID-Profile: Li Zhang
Förderung
- Sichuan Provincial Administration of Traditional Chinese Medicine
- Sichuan Science and Technology Department
Zitieren
APA
Qiu, C., Chen, Y., Xia, H., Duan, J., Zhang, L., Zhang, Y., Chen, Z., & Zhang, L. (2025). Hsa_circ_0004662 Accelerates the Progression of Ulcerative Colitis via the microRNA‐532/HMGB3 Signalling Axis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70430
Vancouver
Qiu C, Chen Y, Xia H, Duan J, Zhang L, Zhang Y, et al. Hsa_circ_0004662 Accelerates the Progression of Ulcerative Colitis via the microRNA‐532/HMGB3 Signalling Axis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70430
BibTeX
@article{Qiu2025,
author = {Qiu, Chunhua and Chen, Yun and Xia, Huan and Duan, Jun and Zhang, Lu and Zhang, You and Chen, Ziyang and Zhang, Li},
title = {Hsa_circ_0004662 Accelerates the Progression of Ulcerative Colitis via the microRNA‐532/HMGB3 Signalling Axis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70430}
}
EUVIMED